J P Morgan India Private ltd has submitted to the Exchange a copy of Open offer for acquisition of up to 415,586,443 equity shares of Rs. 10 each ( Equity Shares ) of the company representing 26.00% of the Expanded Voting Share Capital from the Public Shareholders by Emirates NBD Bank (P.J.S.C.) pursuant to and in compliance with the requirements of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (the SEBI (SAST) Regulations ) (the Open Offer / Offer ).
RBLBANK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Smallcap 250 and 0.2 pts less than its Private Sector Bank peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Emirates NBD Bank (P.J.S.C.), a Dubai-based foreign bank, has initiated an open offer to acquire up to 415,586,443 equity shares of RBL Bank Limited, representing 26% of the Expanded Voting Share Capital. The offer price is ₹280 per equity share. SEBI has issued an observation letter dated April 13, 2026, but the dispatch of the Letter of Offer is pending receipt of several statutory approvals including DPIIT Approval, RBI approval for amended board composition, shareholder approvals, and SEBI approval for change in control of various licenses. The tendering period will commence within twelve working days from receipt of the last required approval. If there is any delay in payment beyond the statutory timeframe, shareholders will receive interest at 10% per annum.
This open offer, if completed, would bring significant foreign ownership into RBL Bank, potentially strengthening the bank's capital base. The ₹280 offer price represents a premium to market and provides existing public shareholders an exit opportunity. However, completion is contingent on multiple regulatory approvals which may cause short-term uncertainty.